7月17日，再鼎医药盘中下跌5.05%，报15.33港元/股，成交额4814.93万港元。
再鼎医药所在的生物科技行业中，个股普遍走弱，康方生物跌12.08%，信达生物跌5.73%，三生制药跌11.73%，科伦博泰生物跌6.26%，百济神州跌2.78%。
再鼎医药有限公司是一家主要从事生物制药业务的控股公司，致力于通过产品的发现、开发和商业化解决肿瘤、免疫、神经科学和感染性疾病领域未被满足的医疗需求，拥有从发现阶段到临床项目后期的一系列专利候选药物。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.